T1	Participants 101 129	metastatic colorectal cancer
T2	Participants 150 214	two consecutive southern Italy cooperative oncology group trials
T3	Participants 399 469	2 consecutive randomized trials in metastatic colorectal cancer (CRC).
T4	Participants 510 522	254 patients
T5	Participants 1782 1798	elderly patients
